{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:04:57Z","timestamp":1789538697024,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hematopoietic stem cell transplantation (HSCT) represents a curative therapeutic modality for children, adolescents, and young-adult (CAYA) patients with various life-threatening hematological malignancies and non- malignant haematological disorders. Conditioning regimens, a cornerstone of HSCT, typically involve total body irradiation (TBI) or busulfan (Bu)-based myeloablation. However, the optimal conditioning strategy for CAYA populations remains controversial, and high-quality evidence regarding long-term complications is lacking. This systematic review and meta-analysis aimed to comprehensively compare the efficacy and safety profiles of TBI and Bu-based conditioning regimens in CAYA-HSCT recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, ClinicalTrials.gov, Wanfang Data, and CNKI databases from inception to August 3, 2025. Eligible studies included prospective or retrospective cohort studies and randomized controlled trials involving CAYA patients (0\u201325 years) undergoing HSCT with TBI or Bu-based conditioning. Primary outcomes were overall survival (OS), event-free survival (EFS), transplant-related mortality (TRM), and relapse rate. Secondary outcomes included seven key long-term complications: growth retardation, thyroid dysfunction, hypogonadism, secondary tumors, cataracts, neurological complications, and chronic graft-vs.-host disease (cGVHD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 4,928 studies were identified, with 26 ultimately included in the meta-analysis. The results showed that Bu conferred survival benefits for patients with AML and cohorts comprising both malignant and non-malignant disease cases, whereas TBI yielded superior EFS and relapse-control outcomes in ALL patients. Five long-term complications (growth retardation, thyroid dysfunction, hypogonadism, secondary tumors and cataracts) occurred at significantly lower rates in the Bu group. Sex-related heterogeneity was observed for hypogonadism with higher Bu-associated risk in one female- only cohort. No significant differences were observed in neurological complications or cGVHD between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In conclusion, conditioning-regimen selection should be individualized according to disease subtype. For ALL patients, clinicians need to balance the survival- and relapse-preventive advantages of TBI against its long-term toxic effects on children's growth, development and vital organs. For AML patients, the survival benefits of Bu-based conditioning should be weighed against sex- dependent toxic risks. Early preventive-interventional measures and adequate education for patients and guardians are essential for CAYA patients receiving TBI or Bu-based conditioning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1865647","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:32:46Z","timestamp":1789536766000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The complications of irradiation or busulfan for CAYA before hematopoietic stem cell transplantation: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Jiahe","family":"Zhang","sequence":"first","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Wei","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Du","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Peng","sequence":"additional","affiliation":[{"name":"Zhongshan School of Medicine, Sun Yat-sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Laboratory, Division of Hematology\/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Laboratory, Division of Hematology\/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/annonc\/mdm064","article-title":"Hematopoietic cell transplantation: progress and obstacles","volume":"18","author":"Devetten","year":"2007","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","article-title":"Allogeneic stem cell transplantation: a historical and scientific overview","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4103\/1673-5374.233431","article-title":"Neurological complications of hematopoietic cell transplantation in children and adults","volume":"13","author":"Dulamea","year":"2018","journal-title":"Neural Regen Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"775485","DOI":"10.3389\/fped.2021.775485","article-title":"Total body irradiation forever? Optimising chemotherapeutic options for irradiation-free conditioning for paediatric acute lymphoblastic leukaemia","volume":"9","author":"Ben Hassine","year":"2021","journal-title":"Front Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bmt.1701334","article-title":"Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan\/cyclophosphamide vs total body irradiation: a meta-analysis","volume":"22","author":"Hartman","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.exphem.2003.09.008","article-title":"Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?","volume":"31","author":"Ferry","year":"2003","journal-title":"Exp Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00277-003-0680-7","article-title":"Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases","volume":"82","author":"Platzbecker","year":"2003","journal-title":"Ann Hematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10428190903419130","article-title":"Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis","volume":"51","author":"Shi-Xia","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5144\/1658-3876.2011.17","article-title":"Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis","volume":"4","author":"Gupta","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41409-022-01865-6","article-title":"Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis","volume":"58","author":"Luo","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clml.2023.01.004","article-title":"Total body irradiation versus chemotherapy conditioning in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplant: a systematic review and meta-analysis","volume":"23","author":"Rehman","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B14","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2014.3","article-title":"Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study","volume":"49","author":"Bernard","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a pediatric blood and marrow transplant consortium study","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"506.e1","DOI":"10.1016\/j.jtct.2022.05.040","article-title":"Thyroid disorders following hematopoietic stem cell transplantation in childhood: impact of conditioning regimen on thyroid dysfunction, volume changes, and occurrence of nodules","volume":"28","author":"Cattoni","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1182\/blood-2023-190800","article-title":"Longitudinal assessment of pubertal attainment and testicular function following pediatric hematopoietic stem cell transplantation: the role of the conditioning regimen","volume":"142","author":"Cattoni","year":"2023","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1515\/jpem.2011.339","article-title":"Primary ovarian dysfunction after hematopoietic stem cell transplantation during childhood: busulfan-based conditioning is a major concern","volume":"24","author":"Cho","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/bmt.2013.185","article-title":"Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI\u2009+\u2009CY versus BU\u2009+\u2009CY: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"49","author":"De Berranger","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e28079","DOI":"10.1002\/pbc.28079","article-title":"The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Friend","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1601-0825.2011.01821.x","article-title":"Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI","volume":"17","author":"Garming-Legert","year":"2011","journal-title":"Oral Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/bjh.18691","article-title":"Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome","volume":"201","author":"Hama","year":"2023","journal-title":"Br J Haematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/bjh.13148","article-title":"Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study","volume":"168","author":"Horwitz","year":"2015","journal-title":"Br J Haematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/08880018.2020.1738604","article-title":"Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens","volume":"37","author":"Huttunen","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.bbmt.2015.08.011","article-title":"Comparison of outcomes for pediatric patients with acute myeloid leukemia in remission and undergoing allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens based on either intravenous busulfan or total body irradiation: a report from the Japanese Society for Hematopoietic Cell Transplantation","volume":"21","author":"Ishida","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjh.13174","article-title":"Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation","volume":"168","author":"Kato","year":"2015","journal-title":"Br J Haematol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4149\/neo_2020_200214N131","article-title":"Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood","volume":"67","author":"Keslova","year":"2020","journal-title":"Neoplasma"},{"key":"B29","doi-asserted-by":"publisher","first-page":"502.e1","DOI":"10.1016\/j.jtct.2022.05.028","article-title":"Comparison of pulmonary toxicity after total body irradiation- and busulfan-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"28","author":"Liu","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41409-020-01180-y","article-title":"Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. Study","volume":"56","author":"Lopez","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbmt.2016.11.022","article-title":"Impact of conditioning regimen on outcomes for children with acute myeloid leukemia undergoing transplantation in first complete remission. An analysis on behalf of the pediatric disease working party of the European Group for Blood and Marrow Transplantation","volume":"23","author":"Lucchini","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/08880010902976742","article-title":"Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish working party for blood and marrow transplantation in children (GETMON)","volume":"26","author":"Mu\u00f1oz","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1097\/MPH.0000000000001455","article-title":"Role of initiating supportive care preceding veno-occlusive disease diagnosis following allogeneic hematopoietic stem cell transplantation in children","volume":"41","author":"Rayner","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41409-020-0806-8","article-title":"Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study","volume":"55","author":"Saglio","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1704537","article-title":"Outcomes of unrelated cord blood transplantation in pediatric recipients","volume":"34","author":"Styczynski","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"812.e1","DOI":"10.1016\/j.jtct.2024.05.014","article-title":"Effects of total body irradiation on hematopoietic cell transplantation outcomes in pediatric acute myeloid leukemia with prior central nervous system involvement","volume":"30","author":"Takahashi","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13773","DOI":"10.1111\/petr.13773","article-title":"Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed","volume":"24","author":"Weinhard","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/bmt.2015.43","article-title":"Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up","volume":"50","author":"Wilhelmsson","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MPH.0000000000002055","article-title":"Comparison of total body irradiation-based versus chemotherapy-based conditionings for early complications of allogeneic hematopoietic stem cell transplantation in children with ALL","volume":"43","author":"Yalcin","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1182\/blood-2013-07-514448","article-title":"Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI","volume":"122","author":"Copelan","year":"2013","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S2352-4642(24)00167-6","article-title":"Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study","volume":"8","author":"Kahn","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41409-020-01038-3","article-title":"Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism","volume":"56","author":"Mejdahl Nielsen","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-13-0694","article-title":"Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence","volume":"170","author":"Vatanen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-022-01284-6","article-title":"Worked to the bone: antibody-based conditioning as the future of transplant biology","volume":"15","author":"Griffin","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/10428194.2018.1493734","article-title":"Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia","volume":"60","author":"Speziali","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3324\/haematol.2020.249458","article-title":"Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children","volume":"106","author":"Dandoy","year":"2021","journal-title":"Haematologica"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1865647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:32:47Z","timestamp":1789536767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1865647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":48,"alternative-id":["10.3389\/fped.2026.1865647"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1865647","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1865647"}}